Annual SG&A
$88.49 M
+$3.21 M+3.77%
31 December 2023
Summary:
REGENXBIO annual selling, general & administrative expenses is currently $88.49 million, with the most recent change of +$3.21 million (+3.77%) on 31 December 2023. During the last 3 years, it has risen by +$24.68 million (+38.67%). RGNX annual SG&A is now at all-time high.RGNX Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$19.42 M
+$567.00 K+3.01%
30 September 2024
Summary:
REGENXBIO quarterly selling, general & administrative expenses is currently $19.42 million, with the most recent change of +$567.00 thousand (+3.01%) on 30 September 2024. Over the past year, it has dropped by -$3.66 million (-15.86%). RGNX quarterly SG&A is now -18.04% below its all-time high of $23.70 million, reached on 30 June 2023.RGNX Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$3.18 B
-$238.81 M-8.13%
30 September 2024
Summary:
REGENXBIO TTM selling, general & administrative expenses is currently -$3.18 billion, with the most recent change of -$238.81 million (-8.13%) on 30 September 2024. Over the past year, it has dropped by -$3.27 billion (-3604.28%). RGNX TTM SG&A is now -10923.48% below its all-time high of $90.63 million, reached on 30 September 2023.RGNX TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RGNX Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +3.8% | -15.9% | -3604.3% |
| 3 y3 years | +38.7% | -7.7% | -4342.0% |
| 5 y5 years | +140.2% | +56.6% | -6646.7% |
RGNX Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +38.7% | -18.0% | +6.2% | -192.2% | at low |
| 5 y | 5 years | at high | +140.2% | -18.0% | +56.6% | -580.8% | at low |
| alltime | all time | at high | +2197.9% | -18.0% | +1715.1% | <-9999.0% | at low |
REGENXBIO Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $19.42 M(+3.0%) | $75.65 M(-4.6%) |
| June 2024 | - | $18.86 M(+3.1%) | $79.31 M(-5.8%) |
| Mar 2024 | - | $18.29 M(-4.1%) | $84.15 M(-4.9%) |
| Dec 2023 | $88.49 M(+3.8%) | $19.08 M(-17.3%) | $88.49 M(-2.4%) |
| Sept 2023 | - | $23.08 M(-2.6%) | $90.63 M(+2.4%) |
| June 2023 | - | $23.70 M(+4.7%) | $88.46 M(+3.3%) |
| Mar 2023 | - | $22.63 M(+6.7%) | $85.60 M(+0.4%) |
| Dec 2022 | $85.28 M(+7.5%) | $21.21 M(+1.4%) | $85.28 M(-1.0%) |
| Sept 2022 | - | $20.92 M(+0.4%) | $86.11 M(-0.1%) |
| June 2022 | - | $20.83 M(-6.7%) | $86.22 M(+2.9%) |
| Mar 2022 | - | $22.32 M(+1.3%) | $83.81 M(+5.6%) |
| Dec 2021 | $79.33 M(+24.3%) | $22.04 M(+4.8%) | $79.33 M(+6.0%) |
| Sept 2021 | - | $21.03 M(+14.1%) | $74.86 M(+7.4%) |
| June 2021 | - | $18.43 M(+3.3%) | $69.69 M(+4.3%) |
| Mar 2021 | - | $17.84 M(+1.5%) | $66.82 M(+4.7%) |
| Dec 2020 | $63.82 M(+23.2%) | $17.57 M(+10.8%) | $63.82 M(+5.1%) |
| Sept 2020 | - | $15.86 M(+2.0%) | $60.70 M(+6.0%) |
| June 2020 | - | $15.55 M(+4.9%) | $57.24 M(+3.9%) |
| Mar 2020 | - | $14.83 M(+2.7%) | $55.09 M(+6.3%) |
| Dec 2019 | $51.81 M | $14.45 M(+16.5%) | $51.81 M(+6.8%) |
| Sept 2019 | - | $12.40 M(-7.5%) | $48.51 M(+7.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2019 | - | $13.40 M(+16.0%) | $45.12 M(+12.7%) |
| Mar 2019 | - | $11.56 M(+3.7%) | $40.03 M(+8.6%) |
| Dec 2018 | $36.85 M(+35.3%) | $11.14 M(+23.7%) | $36.85 M(+20.8%) |
| Sept 2018 | - | $9.01 M(+8.3%) | $30.51 M(-1.4%) |
| June 2018 | - | $8.32 M(-0.7%) | $30.95 M(+6.8%) |
| Mar 2018 | - | $8.38 M(+74.3%) | $28.99 M(+6.5%) |
| Dec 2017 | $27.23 M(+15.4%) | $4.81 M(-49.1%) | $27.23 M(-3.3%) |
| Sept 2017 | - | $9.44 M(+48.6%) | $28.16 M(+13.0%) |
| June 2017 | - | $6.36 M(-4.0%) | $24.92 M(+0.8%) |
| Mar 2017 | - | $6.62 M(+15.3%) | $24.73 M(+4.8%) |
| Dec 2016 | $23.59 M(+98.0%) | $5.74 M(-7.4%) | $23.59 M(+6.8%) |
| Sept 2016 | - | $6.20 M(+0.5%) | $22.09 M(+19.7%) |
| June 2016 | - | $6.17 M(+12.6%) | $18.46 M(+17.7%) |
| Mar 2016 | - | $5.48 M(+29.2%) | $15.68 M(+31.6%) |
| Dec 2015 | $11.91 M(+209.3%) | $4.24 M(+65.2%) | $11.92 M(+35.5%) |
| Sept 2015 | - | $2.57 M(-24.4%) | $8.80 M(+20.5%) |
| June 2015 | - | $3.40 M(+98.0%) | $7.30 M(+87.0%) |
| Mar 2015 | - | $1.72 M(+53.4%) | $3.90 M(+78.4%) |
| Dec 2014 | $3.85 M(-29.6%) | $1.12 M(+4.6%) | $2.19 M(+104.6%) |
| Sept 2014 | - | $1.07 M | $1.07 M |
| Dec 2013 | $5.47 M | - | - |
FAQ
- What is REGENXBIO annual selling, general & administrative expenses?
- What is the all time high annual SG&A for REGENXBIO?
- What is REGENXBIO annual SG&A year-on-year change?
- What is REGENXBIO quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for REGENXBIO?
- What is REGENXBIO quarterly SG&A year-on-year change?
- What is REGENXBIO TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for REGENXBIO?
- What is REGENXBIO TTM SG&A year-on-year change?
What is REGENXBIO annual selling, general & administrative expenses?
The current annual SG&A of RGNX is $88.49 M
What is the all time high annual SG&A for REGENXBIO?
REGENXBIO all-time high annual selling, general & administrative expenses is $88.49 M
What is REGENXBIO annual SG&A year-on-year change?
Over the past year, RGNX annual selling, general & administrative expenses has changed by +$3.21 M (+3.77%)
What is REGENXBIO quarterly selling, general & administrative expenses?
The current quarterly SG&A of RGNX is $19.42 M
What is the all time high quarterly SG&A for REGENXBIO?
REGENXBIO all-time high quarterly selling, general & administrative expenses is $23.70 M
What is REGENXBIO quarterly SG&A year-on-year change?
Over the past year, RGNX quarterly selling, general & administrative expenses has changed by -$3.66 M (-15.86%)
What is REGENXBIO TTM selling, general & administrative expenses?
The current TTM SG&A of RGNX is -$3.18 B
What is the all time high TTM SG&A for REGENXBIO?
REGENXBIO all-time high TTM selling, general & administrative expenses is $90.63 M
What is REGENXBIO TTM SG&A year-on-year change?
Over the past year, RGNX TTM selling, general & administrative expenses has changed by -$3.27 B (-3604.28%)